SIMRISE: A randomized phase III trial evaluating SIM0270 in combination with everolimus versus treatment of physician’s choice in patients with ER+/HER2- advanced breast cancer, previously treated with CDK4/6 inhibitors.

Authors: Jiong Wu, Jian Zhang, Yongmei Yin, Yehui Shi, Xinhong Wu, Tao Sun, Chen Yang, Lili Zhu, Ya Li, Chunyan He

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps1128

Source: Full article

TPS1128